A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing

por Metcalfe, K A, Poll, A, Royer, R, Nanda, S, Llacuachaqui, M, Sun, P, Narod, S A
Publicado 2013

BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane

por Kotsopoulos, J, Zhang, S, Akbari, M, Salmena, L, Llacuachaqui, M, Zeligs, M, Sun, P, Narod, S A
Publicado 2014

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

por Iqbal, J, Ragone, A, Lubinski, J, Lynch, H T, Moller, P, Ghadirian, P, Foulkes, W D, Armel, S, Eisen, A, Neuhausen, S L, Senter, L, Singer, C F, Ainsworth, P, Kim-Sing, C, Tung, N, Friedman, E, Llacuachaqui, M, Ping, S, Narod, S A
Publicado 2012

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

por Phelan, C M, Iqbal, J, Lynch, H T, Lubinski, J, Gronwald, J, Moller, P, Ghadirian, P, Foulkes, W D, Armel, S, Eisen, A, Neuhausen, S L, Senter, L, Singer, C F, Ainsworth, P, Kim-Sing, C, Tung, N, Llacuachaqui, M, Chornokur, G, Ping, S, Narod, S A
Publicado 2014